Silvia Prosperi

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

HLM Staging and Treatment Benefit of SGLT2i Across Heart Failure Severity.

HLM Staging and Treatment Benefit of SGLT2i Across Heart Failure Severity.

Journal: Journal of cardiovascular development and disease

Published: May 30, 2026

Vericiguat therapy reduces arrhythmic events in patients with heart failure and cardiac implantable electronic devices.

Vericiguat therapy reduces arrhythmic events in patients with heart failure and cardiac implantable electronic devices.

Journal: Heart rhythm

Published: May 20, 2026

Multi-Chamber Reverse Remodeling and Hemodynamic Force Realignment After SGLT2 Inhibitor Initiation in Real-World Heart Failure.

Multi-Chamber Reverse Remodeling and Hemodynamic Force Realignment After SGLT2 Inhibitor Initiation in Real-World Heart Failure.

Journal: Journal of cardiovascular development and disease

Published: April 13, 2026

Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF.

Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: June 03, 2025

Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology.

Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology.

Journal: Cardiovascular drugs and therapy

Published: May 02, 2025

Implications of Oxidative Stress in the Pathophysiological Pathways of Heart Failure.

Implications of Oxidative Stress in the Pathophysiological Pathways of Heart Failure.

Journal: International journal of molecular sciences

Published: April 19, 2025

A novel insight into the athlete's heart: Hemodynamic forces evaluation by cardiovascular magnetic resonance.

A novel insight into the athlete's heart: Hemodynamic forces evaluation by cardiovascular magnetic resonance.

Journal: International journal of cardiology

Published: March 14, 2025

Cardiac contractility modulation: from molecular patterns to tailored treatment in heart failure subgroups.

Cardiac contractility modulation: from molecular patterns to tailored treatment in heart failure subgroups.

Journal: Minerva cardiology and angiology

Published: November 20, 2024

MicroRNA and Heart Failure: A Novel Promising Diagnostic and Therapeutic Tool.

MicroRNA and Heart Failure: A Novel Promising Diagnostic and Therapeutic Tool.

Journal: Journal of clinical medicine

Published: November 16, 2024

Deferring Percutaneous Coronary Intervention in Subacute STEMI With Rare Mechanical Complications.

Deferring Percutaneous Coronary Intervention in Subacute STEMI With Rare Mechanical Complications.

Journal: JACC. Case reports

Published: October 16, 2024

SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices.

SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices.

Journal: ESC heart failure

Published: September 25, 2024

Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature.

Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature.

Journal: International journal of molecular sciences

Published: August 31, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026